Probiotics: Sorting the evidence from the myths [1]

Medical Journal of Australia

Volumn 189, Issue 3, 2008, Pages 182-

  Chatterjee, Shimonti ^a   Fraser, John ^a  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ACUTE PANCREATITIS; CLINICAL TRIAL; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DRUG EFFICACY; DRUG INDICATION; ENTERIC FEEDING; HUMAN; INFECTION COMPLICATION; INFECTION RISK; INTENSIVE CARE; INTESTINE ISCHEMIA; LETTER; MORTALITY; EVIDENCE BASED MEDICINE; INTESTINE; ISCHEMIA; NOTE; PANCREATITIS; RANDOMIZED CONTROLLED TRIAL; VASCULARIZATION;

EVIDENCE-BASED MEDICINE; HUMANS; INTESTINES; ISCHEMIA; PANCREATITIS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 50249089727     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2008.tb01969.x     Document Type: Letter

References (4)

1. Pham M, Lemberg DA, Day AS. Probiotics: sorting the evidence from the myths. Med J Aust 2008; 188: 304-308.
2. Besselink MGH, van Santvoort HC, Buskens E, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 371: 651-659.
3. Jain PK, McNaught CE, Anderson AD, et al. Influence of synbiotic containing Lactobacillus acid-ophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial. Clin Nutr 2004; 23: 467-475.
4. Honeycutt TC, El Khashab M, Wardrop RM III, et al. Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: a randomized placebo-controlled trial. Pediatr Crit Care Med 2007; 8: 452-458.